Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aujan Group Holding is a diversified multi-billion dollar conglomerate with a legacy spanning over a century in the Middle East and Africa. The group is best known for its leadership in the fast-moving consumer goods (FMCG) sector, particularly through its beverage brands Rani, Barbican, and Vimto. In 2012, the company entered into a significant multi-billion dollar partnership with The Coca-Cola Company to expand its beverage manufacturing and distribution footprint. In addition to FMCG, Aujan Group Holding maintains a robust portfolio in real estate, hospitality, and industrial solutions. The company does not operate in the life sciences, biotechnology, or pharmaceutical sectors. It remains a privately held entity with headquarters in Saudi Arabia and the United Arab Emirates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aujan Group Holding.